Combined hepatocellular carcinoma-cholangiocarcinoma: Report of MR appearance in eleven patients

被引:41
|
作者
de Campos, Rafael O. P. [1 ]
Semelka, Richard C. [1 ]
Azevedo, Rafael M. [1 ]
Ramalho, Miguel [1 ]
Heredia, Vasco [1 ]
Armao, Diane M. [1 ,2 ]
Woosley, John T. [2 ]
机构
[1] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
关键词
combined hepatocellular-cholangiocarcinoma; mixed; magnetic resonance findings; MR appearance; primary liver tumor; INTRAHEPATIC CHOLANGIOCARCINOMA; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; CT; LIVER; TRANSPLANTATION; METASTASES; PATTERNS; FEATURES;
D O I
10.1002/jmri.23754
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To describe the magnetic resonance imaging (MRI) appearance of hepatic combined hepatocellular-cholangiocarcinoma (cHCC-CC) in 11 patients. Materials and Methods: The database of the Department of Pathology was cross-referenced with the MRI database to identify patients with confirmed cHCC-CC who had undergone MRI. Eleven consecutive patients were included (seven female, mean age 57.6 years). All patients were Caucasian. Five of 11 had a clinical history of chronic liver disease. Two radiologists retrospectively analyzed the images in consensus. Results: cHCC-CC was a single mass in 10/11 patients. Margins were well-defined in 6/11. All tumors showed heterogeneous hyperintensity on T2. On postcontrast imaging, 6/11 showed early ring-enhancement (four noncirrhotic), with progressive enhancement in central portions, and 5/11 patients showed a diffuse heterogeneous early enhancement. Three of these five were cirrhotic and displayed partial washout with portions of contrast retention on later phases. Other findings included: late capsule enhancement (two patients), biliary dilatation (one), venous invasion (three), lymphadenopathy (six), and findings of cirrhosis (five). Conclusion: cHCC-CC presents most commonly as a single mass. Five of 11 had MR findings of cirrhosis. Clues to the diagnosis were moderately high signal on T2, portions of tumor that show progressive enhancement/contrast retention, and frequent lack of capsule. Early enhancement patterns included early ring-enhancement and diffuse heterogeneous enhancement. J. Magn. Reson. Imaging 2012;36:11391147. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1139 / 1147
页数:9
相关论文
共 50 条
  • [31] Reappraisal of Survival Outcomes to Validate Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Palaniappan, Nagarajan
    Lin, Chih-Che
    Chen, Chao-Long
    Lin, Yu-Hung
    Yong, Chee-Chien
    Wu, Yi-Ju
    TRANSPLANTATION, 2016, 100 : S168 - S168
  • [32] Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification
    Jung, Dong-Hwan
    Hwang, Shin
    Hong, Seung-Mo
    Chung, Yong-Kyu
    Song, Gi-Won
    Lee, Young-Joo
    Kim, Ki-Hun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Park, Gil-Chun
    Lee, Han Chu
    Lim, Young-Suk
    Yu, Eun Sil
    Lee, Sung-Gyu
    WORLD JOURNAL OF SURGERY, 2017, 41 (05) : 1347 - 1357
  • [33] MRI appearance of combined hepatocellular cholangiocarcinoma
    Billet, Nicolas
    Gregory, Jules
    Ronot, Maxime
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (12) : 625 - 626
  • [34] MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Zhou, Changwu
    Ni, Xiaoyan
    Lu, Xin
    Wang, Yi
    Qian, Xianling
    Yang, Chun
    Zeng, Mengsu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 975 - 983
  • [35] Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction
    Xiao, Yuyao
    Zheng, Xinde
    Zhou, Changwu
    Huang, Peng
    Wu, Fei
    Yang, Chun
    Zeng, Mengsu
    EUROPEAN RADIOLOGY, 2023, 33 (02) : 1412 - 1421
  • [36] Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction
    Yuyao Xiao
    Xinde Zheng
    Changwu Zhou
    Peng Huang
    Fei Wu
    Chun Yang
    Mengsu Zeng
    European Radiology, 2023, 33 : 1412 - 1421
  • [37] The Use of a Genetic Database to Determine the Etiologies of Biphenotypic Hepatocellular Carcinoma-Cholangiocarcinoma
    Mok, Shaffer R.
    Mohan, Sachin
    Grewal, Navjot
    Elfant, Adam B.
    Judge, Thomas A.
    GASTROENTEROLOGY, 2015, 148 (04) : S965 - S965
  • [38] Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma
    Mitsumaro Itoyama
    Masaki Hata
    Koji Yamanegi
    Naoko Yamada
    Hideki Ohyama
    Hiroshi Hirano
    Nobuyuki Terada
    Keiji Nakasho
    Medical Molecular Morphology, 2012, 45 : 7 - 13
  • [39] Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma
    Itoyama, Mitsumaro
    Hata, Masaki
    Yamanegi, Koji
    Yamada, Naoko
    Ohyama, Hideki
    Hirano, Hiroshi
    Terada, Nobuyuki
    Nakasho, Keiji
    MEDICAL MOLECULAR MORPHOLOGY, 2012, 45 (01) : 7 - 13
  • [40] Comparison of Combined Hepatocellular and Cholangiocarcinoma with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Won-Suk Lee
    Kwang-Woong Lee
    Jin-Seok Heo
    Sung-Ju Kim
    Seong-Ho Choi
    Yong-Il Kim
    Jae-Won Joh
    Surgery Today, 2006, 36 : 892 - 897